DocDollars

Zimmer Biomet Holdings, Inc.

IN · United States · Reporting entity ID 100000000103

Total reported 2019–2025
$881.5M
#19 of 2,960 reporting companies — 1.1% of all reported industry payments
$839.7M in general payments across 341,805 records, plus $33.6M in research funding across 7,002 records.

How it breaks down

General payments $839,743,063
Research funding $33,606,244
Ownership & investment $8,123,810

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Zimmer Biomet Holdings, Inc. reported $881.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #19 of 2,960 reporting companies. 4% of that was research funding and 96% general payments such as consulting, speaking, food and travel. 341,805 general payment records and 7,002 research records were filed.

Common questions about Zimmer Biomet Holdings, Inc.

How much has Zimmer Biomet Holdings, Inc. paid US doctors?

Zimmer Biomet Holdings, Inc. reported $881,473,117 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $839,743,063 in general payments, $33,606,244 in research funding and $8,123,810 in ownership and investment interests.

How does Zimmer Biomet Holdings, Inc. rank among drug and device companies?

It ranks #19 of 2,960 reporting entities by total reported value, about 1.1% of all industry payments in the dataset.

Does a payment from Zimmer Biomet Holdings, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.